Veracyte Stock Price Prediction

VCYT Stock  USD 39.59  0.65  1.67%   
The RSI of Veracyte's the stock price is slightly above 61. This entails that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Veracyte, making its price go up or down.

Oversold Vs Overbought

61

 
Oversold
 
Overbought
The successful prediction of Veracyte's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Veracyte, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Veracyte's stock price prediction:
EPS Estimate Next Quarter
0.07
EPS Estimate Current Year
1.0141
EPS Estimate Next Year
0.8934
Wall Street Target Price
42.7778
EPS Estimate Current Quarter
0.03
Using Veracyte hype-based prediction, you can estimate the value of Veracyte from the perspective of Veracyte response to recently generated media hype and the effects of current headlines on its competitors.

Veracyte Hype to Price Pattern

Investor biases related to Veracyte's public news can be used to forecast risks associated with an investment in Veracyte. The trend in average sentiment can be used to explain how an investor holding Veracyte can time the market purely based on public headlines and social activities around Veracyte. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Veracyte's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Veracyte.
The fear of missing out, i.e., FOMO, can cause potential investors in Veracyte to buy its stock at a price that has no basis in reality. In that case, they are not buying Veracyte because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Veracyte after-hype prediction price

    
  USD 39.37  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Veracyte Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Veracyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
30.2232.9643.55
Details
Naive
Forecast
LowNextHigh
35.0437.7840.51
Details
10 Analysts
Consensus
LowTargetHigh
29.7332.6736.26
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.060.250.28
Details

Veracyte After-Hype Price Prediction Density Analysis

As far as predicting the price of Veracyte at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Veracyte or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Veracyte, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Veracyte Estimiated After-Hype Price Volatility

In the context of predicting Veracyte's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Veracyte's historical news coverage. Veracyte's after-hype downside and upside margins for the prediction period are 36.63 and 42.11, respectively. We have considered Veracyte's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
39.59
39.37
After-hype Price
42.11
Upside
Veracyte is very steady at this time. Analysis and calculation of next after-hype price of Veracyte is based on 3 months time horizon.

Veracyte Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Veracyte is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Veracyte backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Veracyte, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.33 
2.74
  0.22 
  0.17 
11 Events / Month
16 Events / Month
In about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
39.59
39.37
0.56 
408.96  
Notes

Veracyte Hype Timeline

Veracyte is at this time traded for 39.59. The entity has historical hype elasticity of -0.22, and average elasticity to hype of competition of 0.17. Veracyte is anticipated to decline in value after the next headline, with the price expected to drop to 39.37. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.56%, whereas the daily expected return is at this time at 0.33%. The volatility of related hype on Veracyte is about 521.0%, with the expected price after the next announcement by competition of 39.76. About 99.0% of the company outstanding shares are owned by institutional investors. The book value of Veracyte was at this time reported as 15.18. The company recorded a loss per share of 0.13. Veracyte had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days.
Check out Veracyte Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Veracyte Related Hype Analysis

Having access to credible news sources related to Veracyte's direct competition is more important than ever and may enhance your ability to predict Veracyte's future price movements. Getting to know how Veracyte's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Veracyte may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CRNXCrinetics Pharmaceuticals 1.09 11 per month 2.42  0  3.67 (3.45) 16.75 
VRDNViridian Therapeutics 0.52 11 per month 3.45  0.07  6.84 (5.29) 44.89 
CYTKCytokinetics 1.67 12 per month 0.00 (0.14) 3.42 (4.15) 14.08 
GPCRStructure Therapeutics American(1.47)9 per month 0.00 (0.11) 7.41 (6.07) 24.50 
ICVXIcosavax(0.11)1 per month 4.56  0.13  10.22 (6.79) 38.57 
KURAKura Oncology(0.20)11 per month 0.00 (0.19) 4.47 (4.04) 12.85 
PTGXProtagonist Therapeutics 0.65 10 per month 2.35 (0.03) 3.42 (3.74) 14.61 
MRUSMerus BV 2.84 8 per month 0.00 (0.18) 3.08 (2.83) 10.85 
REPLReplimune Group(0.06)7 per month 3.28  0.02  7.23 (5.60) 15.63 
CERECerevel Therapeutics Holdings 0.20 9 per month 0.94 (0.02) 1.91 (1.59) 6.40 
ENTAEnanta Pharmaceuticals(0.26)6 per month 0.00 (0.21) 3.86 (4.71) 11.52 
SNDXSyndax Pharmaceuticals(0.06)10 per month 0.00 (0.10) 4.02 (4.33) 34.00 
VTYXVentyx Biosciences(0.02)7 per month 0.00 (0.05) 6.88 (5.86) 22.25 
QUREUniqure NV 0.14 9 per month 0.00 (0.04) 11.07 (7.40) 36.04 
RCKTRocket Pharmaceuticals(0.84)11 per month 0.00 (0.19) 5.11 (6.38) 21.07 
RYTMRhythm Pharmaceuticals 4.26 9 per month 2.56  0.10  7.37 (4.90) 17.61 
SLDBSolid Biosciences LLC(0.68)6 per month 0.00 (0.22) 5.73 (8.66) 24.49 
MGTXMeiraGTx Holdings PLC 0.59 9 per month 2.64  0.11  5.71 (5.68) 21.07 
IDYAIdeaya Biosciences 0.02 7 per month 0.00 (0.23) 4.15 (5.09) 15.21 
ANABAnaptysBio 2.33 9 per month 0.00 (0.16) 5.30 (7.28) 35.57 
KROSKeros Therapeutics 0.97 10 per month 2.34  0.05  4.39 (4.61) 16.94 
FIXXHomology Medicines(0.01)2 per month 3.52  0.01  5.77 (5.61) 19.43 

Veracyte Additional Predictive Modules

Most predictive techniques to examine Veracyte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Veracyte using various technical indicators. When you analyze Veracyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Veracyte Predictive Indicators

The successful prediction of Veracyte stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Veracyte, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Veracyte based on analysis of Veracyte hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Veracyte's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Veracyte's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding68.9454.1840.8235.03
PTB Ratio2.551.581.911.82

Story Coverage note for Veracyte

The number of cover stories for Veracyte depends on current market conditions and Veracyte's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Veracyte is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Veracyte's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Veracyte Short Properties

Veracyte's future price predictability will typically decrease when Veracyte's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Veracyte often depends not only on the future outlook of the potential Veracyte's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Veracyte's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding72.6 M
Cash And Short Term Investments216.5 M

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.